Over the past three months, shares of SpartanNash (NASDAQ:SPTN) decreased by 4.70%. Before having a look at the importance of debt, let us look at how much debt SpartanNash has.
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.
Looking at Q1, SpartanNash (NASDAQ:SPTN) earned $30.20 million, a 73.47% increase from the preceding quarter. SpartanNash also posted a total of $2.66 billion in sales, a 18.29% increase since Q4. In Q4, SpartanNash earned $17.41 million, and total sales reached $2.25 billion.
Amazon.com Inc (NASDAQ: AMZN) uses its size to acquire warrants or rights to purchase the stock of its publicly traded suppliers at steep discounts to market value, the
Looking at Q1, SpartanNash (NASDAQ:SPTN) earned $30.20 million, a 73.47% increase from the preceding quarter. SpartanNash also posted a total of $2.66 billion in sales, a 18.29% increase since Q4. In Q4, SpartanNash earned $17.41 million, and total sales reached $2.25 billion.
Understanding Value Stocks
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
Shares of SpartanNash (NASDAQ:SPTN) decreased in after-market trading after the company reported Q1 results.
Quarterly Results
Earnings per share were down 16.42% year over year to $0.56, which were in line with the estimate of $0.56.
SpartanNash (NASDAQ:SPTN) reported quarterly earnings of $0.56 per share which met the analyst consensus estimate. This is a 16.42 percent decrease over earnings of $0.67 per share from the same period last year. The
Phyto Extractions Announces Departure Of Interim CEO
Phyto Extractions Inc., formerly known as Adastra Labs Holdings Ltd., (CSE: XTRX) (FRA: D2EP), said last Friday it had parted ways with J. Scott Munro, the company’s interim CEO and director.